Jinflexin A is primarily used in advanced biomedical research for its unique anti-inflammatory and immunomodulatory properties. It has shown promise in preclinical studies for treating autoimmune disorders such as rheumatoid arthritis and multiple sclerosis by selectively inhibiting key inflammatory pathways. Its ability to cross the blood-brain barrier makes it a candidate for neuroinflammatory conditions. Additionally, Jinflexin A is being explored for its potential in oncology, where it may help reduce tumor progression by modulating the tumor microenvironment. Due to its specificity and low cytotoxicity, it is also utilized in the development of targeted drug delivery systems and as a reference compound in high-throughput screening assays for new anti-inflammatory agents.